A novel cytotoxic agent for human carcinoid tumors

Surgery

Volumn 124, Issue 6, 1998, Pages 1071-1076

  Litvak, D A ^a   Papaconstantinou, H T ^a   Ko, T C ^a   Townsend C M , Jr ^a   Fabri, P J ^a   Moley, J F ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,19 BIS(ETHYLAMINO) 5,10,15 TRIAZANONADECANE; CARBON 14; CARBON DIOXIDE; CYTOTOXIC AGENT; EFLORNITHINE; ORNITHINE DECARBOXYLASE; POLYAMINE; PUTRESCINE; SPERMIDINE; SPERMINE; UNCLASSIFIED DRUG;

ARTICLE; CARCINOID; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; TUMOR CELL LINE;

EID: 0031731646     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.1998.91830     Document Type: Article

References (25)

1. PC Neary PH Redmond T Houghton GRK Watson D. Bouchier-Hayes Carcinoid disease: review of the literature Dis Colon Rectum 40 1997 349 362
2. MA Memon H. Nelson Gastrointestinal carcinoid tumors: current management strategies Dis Colon Rectum 40 1997 1101 1118
3. CG Moertel JA. Hanley Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome Cancer Clin Trials 2 1979 327 334
4. LK. Kvols Metastatic carcinoid tumors and the carcinoid syndrome: a selective review of chemotherapy and hormonal therapy Am J Med 81 1986 49 55
5. PF Engstrom PT Lavin CG Moertel E Folsch HO Douglass Jr. Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor J Clin Oncol 2 1984 1255 1259
6. RJ Pelley RM. Bukowski Recent advances in diagnosis and therapy of neuroendocrine tumors of the gastrointestinal tract Curr Opin Oncol 9 1997 68 74
7. K. Oberg Endocrine tumors of the gastrointestinal tract: systemic treatment Anticancer Drugs 5 1994 503 519
8. BM Evers CM Townsend Jr JR Upp E Allen SC Hurlbut SW Kim Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth Gastroenterology 101 1991 303 311
9. R Saydjari CM Townsend Jr SC Barranco JC. Thompson Polyamines in gastrointestinal cancer Dig Dis Sci 34 1989 1629 1636
10. G Scalabrino E Lorenzini ME. Ferioli Polyamines and mammalian hormones, part I: biosynthesis, interconversion and hormone effects Mol Cell Endocrinol 77 1991 1 35
11. BM Evers SC Hurlbut SK Tyring CM Townsend Jr T Uchida JC. Thompson Novel therapy for the treatment of human carcinoid Ann Surg 213 1991 411 416
12. BM Evers J Ishizuka CM Townsend Jr JC. Thompson The human carcinoid cell line, BON: a model system for the study of carcinoid tumors Ann NY Acad Sci 733 1994 393 406
13. Y Horn PJ Schechter LJ Marton Phase I-II clinical trial with α-difluoromethylornithine—an inhibitor of polyamine biosynthesis Eur J Cancer Clin Oncol 23 1987 1103 1107
14. G Bepler DN Carney MM Nau AF Gazdar JD Minna Additive and differential biological activity of α-interferon A, difluoromethylornithine, and their combination on established human lung cancer cell lines Cancer Res 46 1986 3413 3419
15. R Saydjari CM Townsend Jr SC Barranco JC. Thompson Cyclosporin and alpha-difluoromethylornithine exhibit differential effects on colon and pancreatic cancer in vitro Invest New Drugs 5 1987 251 258
16. HS Basu HC Schwietert BG Feuerstein LJ. Marton Effects of variation in the structure of spermine on the association with DNA and the induction of DNA conformational changes Biochem J 269 1990 329 334
17. HS Basu M Pellari BG Feuerstein A Shirahata K Samejima DF Deen Interaction of a polyamine analogue, 1,19-bis-(ethylamino)-5,10,15-triazanonadecane (BE-4-4-4-4), with DNA and effect on growth, survival, and polyamine levels in seven human brain tumor cell lines Cancer Res 53 1993 3948 3955
18. ME Dolan MJ Fleig BG Feuerstein HS Basu GD Luk RA Casero Jr Effect of 1,19-bis(ethylamino)-5,10,15-triazanonadecane on human tumor xenografts Cancer Res 54 1994 4698 4702
19. CJ Bergeron HS Basu LJ Marton DF Deen M Pellarin BG. Feuerstein Two polyamine analogs (BE-4-4-4 and BE-4-4-4-4) directly affect growth, survival, and cell cycle progression in two human brain tumor cell lines Cancer Chemother Pharmacol 36 1995 411 417
20. RM Auchter MA Pickart GA Nash RP Qu PM. Harari Growth inhibition of squamous cell carcinoma xenografts with the polyamine analogue BE-4-4-4-4 Arch Otolaryngol Head Neck Surg 122 1996 977 981
21. L Jeffers D Church H Basu L Marton G. Wilding Effects of the polyamine analogues BE-4-4-4-4, BE-3-7-3, and BE-3-3-3 on the proliferation of three prostate cancer cell lines Cancer Chemother Pharmacol 40 1997 172 179
22. CW Porter AE Pegg B Ganis R Madhabala RJ. Bergeron Combined regulation of ornithine and S-adenosylmethionine decarboxylases by spermine and the spermine analogue N1N12-bis(ethyl)spermine Biochem J 268 1990 207 212
23. HS Basu IV Smirnov H Peng K Tiffany V. Jackson Effects of spermine and its cytotoxic analogs on nucleosome formation on topologically stressed DNA in vitro Eur J Biochem 243 1997 247 258
24. CW Porter B Ganis PR Libby RJ Bergeron Correlations between polyamine analogue–induced increases in spermidine/spermine N1-acetyltransferase activity, polyamine pool depletion, and growth inhibition in human melanoma cell lines Cancer Res 51 1991 3715 3720
25. R Gryfe C Swallow B Bapat M Redston S Gallinger J. Couture Molecular biology by colorectal cancer Curr Probl Cancer 21 1997 233 300